Scienture Holdings, Inc. (SCNX) Stock Forecast
SCNX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $37.50 average of analyst targets
- Upside to target
- +1,016.1% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $-1.50
- 52-week range
- $3.24 – $65.00
SCNX analyst ratings
1 analystsNumber of analysts at each rating.
SCNX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SCNX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.50 | −$1.50 | −$1.50 | — | — | 1 |
| Current fiscal year (2026) | −$5.75 | −$5.75 | −$5.75 | — | — | 1 |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | −$5.75 | +100.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SCNX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.6M | $1.6M | $1.6M | — | 1 |
| Current fiscal year (2026) | $4.8M | $4.8M | $4.8M | +1,009.6% | 1 |
| Next fiscal year (2027) | $17.2M | $17.2M | $17.2M | +259.5% | 1 |
SCNX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SCNX revenue: reported and forecast
SCNX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$4.50 | −$2.00 | −$2.00 | −$2.00 | −$1.50 | −66.7% | 1 up · 0 down |
| Current fiscal year (2026) | −$18.00 | −$7.50 | −$7.50 | −$7.50 | −$5.75 | −68.1% | 1 up · 0 down |
| Next fiscal year (2027) | −$5.25 | −$1.50 | −$1.50 | −$1.50 | $0.00 | −100.0% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SCNX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SCNX beat in 3 of 5.
What analysts expect from SCNX
1 analysts cover Scienture; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $37.50, 1,016.1% above the latest close of $3.36. Analysts expect earnings of −$5.75 per share for 2026. For 2027 the average estimate is $0.00 per share on revenue of $17.2 million. Scienture beat the EPS estimate in 3 of the last 5 quarters.
Related: SCNX income statement, SCNX key metrics, SCNX chart. See the SCNX stock overview for the latest quote and news.
SCNX forecast FAQ
What is Scienture's price target?
The average analyst price target for Scienture is $37.50, 1,016.1% above the latest close of $3.36.
Is Scienture a buy, hold or sell?
Of 1 analysts covering Scienture, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Scienture's EPS forecast?
Analysts forecast −$5.75 per share for 2026 (range −$5.75 to −$5.75); for 2027 the estimate is $0.00.
What is Scienture's revenue forecast?
The average revenue estimate for 2026 is $4.8 million, growth of 1,009.6%; for 2027 it is $17.2 million.
When does Scienture report earnings?
Scienture is expected to report results for the quarter ending September 30, 2026 on November 11, 2026; the EPS estimate is $-1.50.
Does Scienture usually beat earnings estimates?
Scienture reported EPS at or above the analyst estimate in 3 of the last 5 quarters.